Citeline Podcasts

When might the first COVID-19 vaccine arrive, which companies might get there first, and just how good that vaccine or vaccine needs to be at protecting the world against Sars-COV2? A look at the competitors and the challenges facing them and global healthcare systems. Including an exclusive interview with one of the frontrunners, China’s CanSino Biologics.

Hosted by Andrew McConaghie and Kevin Grogan from the Scrip Pharma Intelligence team

Pink Sheet reporter and editors discuss the lower new drug submission rate in 2020, another EUA for a potential coronavirus treatment, and the biosimilar user fee program missing revenue estimates again.

Join us for an audio catch-up on the latest key developments in the worldwide biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.

This week’s Device Week podcast covers the recent American Diabetes Association conference, which was held online for the first time. The major diabetes device makers – Abbott, Medtronic and Dexcom – used the meeting to announce new clinical data and explain their diabetes product pipeline to customers and investors.

Listen to the podcast via the player below:

Medtech Insight articles addressing topics discussed in this episode:

ADA 2020: Abbott Expects CGM To Reduce Insulin Needed For Type 2 Diabetes

https://bit.ly/2NbZmOZ

ADA 2020: Medtronic Explains Strategy To Return Growth To Diabetes Business

https://bit.ly/3dkyCX4

ADA 2020: Tandem Wins FDA Nod For T:Slim Pump Technology In Children; Positive Feedback on Studies

https://bit.ly/2AHtDmh

ADA 2020: CGM Maker Dexcom Gains CE Mark, Launches G6 Pro While Rivalry With Abbott Builds

https://bit.ly/2YLiZ5S

Pink Sheet reporter and editor discuss Operation Warp Speed’s manufacturing goals, the US FDA’s decision to pull the hydroxychloroquine EUA, and the race to beat the deadline to remain eligible for a rare pediatric disease priority review voucher.

OCE In the Lockdown: An Interview with Richard Pazdur by Citeline

FDA's CURE ID Database Expands to Include COVID-19 Drugs

On this week’s podcast we discuss some recent news out of the US FDA about its efforts to harmonize its Quality System Regulation with international quality systems standard ISO 13485.

Medtech Insight articles addressing topics discussed in this episode:

Q&A: New Details Emerge From FDA About Long-Delayed Draft Rule That Harmonizes Quality System Reg With ISO 13485

For FDA, The Third Time Wasn’t The Charm For Releasing A Draft Of Its Harmonized Quality System Reg

FDA’s Retooled Quality System Regulation Coming ‘Sometime This Year,’ CDRH Chief Shuren Says

Pink Sheet reporters and editor discuss Merck CEO Ken Frazier’s thoughts on racial inequity, US FDA Commissioner Stephen Hahn’s explanation of coronavirus-related decision-making and changes at Operation Warp Speed, as well as consider fears user fee goal delays may be imminent.

In this edition of Device Week, Medtech Insight’s Reed Miller chats to Marion Webb about strategies medtech businesses can take to recover from the COVID-19 pandemic. He also discusses a new $100M Pandemic Innovation Fund created by Israeli crowd investing fund OurCrowd with reporter Catherine Longworth.

For more information on Medtech Insight and to start a free trial, click here: http://bit.y/2w7LnlR

Medtech Insight articles addressing topics discussed in this episode:

• Beyond COVID-19: Industry Insiders Offer 10 Strategies For Medtech Recovery: https://bit.ly/2Xytz0B

• Interview: Lessons Learned From The Pandemic And Five Strategies For Medtech Recovery: https://bit.ly/2AEgdXQ

• MeMed Ready To Partner On IVD Technology That Can Cut Antibiotic Overuse: https://bit.ly/3dCJ6Ch